Antibiotics and Antibiotic Resistance

Pre-clinical and Clinical Trails

In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected.

The main goals of pre-clinical studies are to determine the safe dose for first-in-man study and assess a product's safety profile. Products may include new medical devices, drugs, gene therapy solutions and diagnostic tools.

On average, only one in every 5,000 compounds that enters drug discovery to the stage of preclinical development becomes an approved drug